Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 May;68(5):595–600. doi: 10.1136/jnnp.68.5.595

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation

B Bejjani 1, D Gervais 1, I Arnulf 1, S Papadopoulos 1, S Demeret 1, A Bonnet 1, P Cornu 1, P Damier 1, Y Agid 1
PMCID: PMC1736917  PMID: 10766889

Abstract

OBJECTIVE—To assess the effects of high frequency stimulation of the subthalamic nucleus (STN) on axial symptoms occurring in advanced stages of Parkinson's disease (PD).
METHODS—The efficacy of STN stimulation on total motor disability score (unified Parkinson's disease rating scale (UPDRS) part III) were evaluated in 10 patients with severe Parkinson's disease. The subscores were then studied separately for limb akinesia, rigidity, and tremor, which are known to respond to levodopa, and axial signs, including speech, neck rigidity, rising from a chair, posture, gait, and postural stability, which are known to respond less well to levodopa. Patients were clinically assessed in the "off" and "on" drug condition during a levodopa challenge test performed before surgical implantation of stimulation electrodes and repeated 6 months after surgery under continuous STN stimulation. A complementary score for axial symptoms from the "activities of daily living" (ADL)—that is, speech, swallowing, turning in bed, falling, walking, and freezing—was obtained from each patient's questionnaire (UPDRS, part II).
RESULTS—Improvements in total motor disability score (62%), limb signs (62%), and axial signs (72%) obtained with STN stimulation were statistically comparable with those obtained with levodopa during the preoperative challenge (68%, 69%, and 59%, respectively). When levodopa and STN stimulation were combined there was a further improvement in total motor disability (80%) compared with preoperative levodopa administration. This consisted largely of an additional improvement in axial signs (84%) mainly for posture and postural stability, no further improvement in levodopa responsive signs being found. Axial symptoms from the ADL showed similar additional improvement when levodopa and STN stimulation were combined.
CONCLUSION—These findings suggest that bilateral STN stimulation improves most axial features of Parkinson's disease and that a synergistic effect can be obtained when stimulation is used in conjunction with levodopa treatment.



Full Text

The Full Text of this article is available as a PDF (162.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agid Y., Cervera P., Hirsch E., Javoy-Agid F., Lehericy S., Raisman R., Ruberg M. Biochemistry of Parkinson's disease 28 years later: a critical review. Mov Disord. 1989;4 (Suppl 1):S126–S144. doi: 10.1002/mds.870040514. [DOI] [PubMed] [Google Scholar]
  2. Agid Y. Parkinson's disease: pathophysiology. Lancet. 1991 Jun 1;337(8753):1321–1324. doi: 10.1016/0140-6736(91)92989-f. [DOI] [PubMed] [Google Scholar]
  3. Barbeau A., Roy M. Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease. Neurology. 1976 May;26(5):399–404. doi: 10.1212/wnl.26.5.399. [DOI] [PubMed] [Google Scholar]
  4. Bejjani B., Damier P., Arnulf I., Bonnet A. M., Vidailhet M., Dormont D., Pidoux B., Cornu P., Marsault C., Agid Y. Pallidal stimulation for Parkinson's disease. Two targets? Neurology. 1997 Dec;49(6):1564–1569. doi: 10.1212/wnl.49.6.1564. [DOI] [PubMed] [Google Scholar]
  5. Benabid A. L., Pollak P., Gross C., Hoffmann D., Benazzouz A., Gao D. M., Laurent A., Gentil M., Perret J. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg. 1994;62(1-4):76–84. doi: 10.1159/000098600. [DOI] [PubMed] [Google Scholar]
  6. Bonnet A. M., Loria Y., Saint-Hilaire M. H., Lhermitte F., Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology. 1987 Sep;37(9):1539–1542. doi: 10.1212/wnl.37.9.1539. [DOI] [PubMed] [Google Scholar]
  7. Dormont D., Cornu P., Pidoux B., Bonnet A. M., Biondi A., Oppenheim C., Hasboun D., Damier P., Cuchet E., Philippon J. Chronic thalamic stimulation with three-dimensional MR stereotactic guidance. AJNR Am J Neuroradiol. 1997 Jun-Jul;18(6):1093–1107. [PMC free article] [PubMed] [Google Scholar]
  8. Escourolle R. Les lésions anatomiques de la maladie de Parkinson et des syndromes parkinsoniens. Ann Med Interne (Paris) 1972 Apr;123(4):349–356. [PubMed] [Google Scholar]
  9. Féger J., Bevan M., Crossman A. R. The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: a comparison with the corticostriatal and corticosubthalamic efferents in a retrograde fluorescent double-labelling study. Neuroscience. 1994 May;60(1):125–132. doi: 10.1016/0306-4522(94)90208-9. [DOI] [PubMed] [Google Scholar]
  10. Garcia-Rill E. The basal ganglia and the locomotor regions. Brain Res. 1986 Mar;396(1):47–63. [PubMed] [Google Scholar]
  11. Giladi N., McMahon D., Przedborski S., Flaster E., Guillory S., Kostic V., Fahn S. Motor blocks in Parkinson's disease. Neurology. 1992 Feb;42(2):333–339. doi: 10.1212/wnl.42.2.333. [DOI] [PubMed] [Google Scholar]
  12. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  13. Jellinger K. Overview of morphological changes in Parkinson's disease. Adv Neurol. 1987;45:1–18. [PubMed] [Google Scholar]
  14. Klawans H. L. Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord. 1986;1(3):187–192. doi: 10.1002/mds.870010304. [DOI] [PubMed] [Google Scholar]
  15. Kumar R., Lozano A. M., Kim Y. J., Hutchison W. D., Sime E., Halket E., Lang A. E. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology. 1998 Sep;51(3):850–855. doi: 10.1212/wnl.51.3.850. [DOI] [PubMed] [Google Scholar]
  16. Lang A. E., Lozano A. M., Montgomery E., Duff J., Tasker R., Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med. 1997 Oct 9;337(15):1036–1042. doi: 10.1056/NEJM199710093371503. [DOI] [PubMed] [Google Scholar]
  17. Lavoie B., Parent A. Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J Comp Neurol. 1994 Jun 8;344(2):190–209. doi: 10.1002/cne.903440203. [DOI] [PubMed] [Google Scholar]
  18. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., Benabid A. L. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998 Oct 15;339(16):1105–1111. doi: 10.1056/NEJM199810153391603. [DOI] [PubMed] [Google Scholar]
  19. Nambu A., Tokuno H., Inase M., Takada M. Corticosubthalamic input zones from forelimb representations of the dorsal and ventral divisions of the premotor cortex in the macaque monkey: comparison with the input zones from the primary motor cortex and the supplementary motor area. Neurosci Lett. 1997 Dec 12;239(1):13–16. doi: 10.1016/s0304-3940(97)00877-x. [DOI] [PubMed] [Google Scholar]
  20. Pahwa R., Wilkinson S., Smith D., Lyons K., Miyawaki E., Koller W. C. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology. 1997 Jul;49(1):249–253. doi: 10.1212/wnl.49.1.249. [DOI] [PubMed] [Google Scholar]
  21. Smith Y., Hazrati L. N., Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol. 1990 Apr 8;294(2):306–323. doi: 10.1002/cne.902940213. [DOI] [PubMed] [Google Scholar]
  22. Steiger M. J., Thompson P. D., Marsden C. D. Disordered axial movement in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):645–648. doi: 10.1136/jnnp.61.6.645. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES